# Carcinoma, Hepatocellular trials, no drug phase: 147 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 147 trials with no drug phase for Carcinoma, Hepatocellular that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Carcinoma, Hepatocellular trials with no drug phase: 147 rows for $7.35, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/carcinoma-hepatocellular

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 147
- Recruiting or not yet: 147
- Read on: November 19, 2026

## Trials

The 25 newest of 147, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07929597 | INPACT: Implementation of Nutritional Support and Physical Activity During Cancer Treatment | General Hospital Groeninge | Not applicable | Not yet recruiting | Primary Liver Cancer, Liver Metastasis | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929597) |
| November 9, 2026 | NCT07924943 | Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation (SBRT) in Patients With Hepatocellular Carcinoma (HCC) Prior to... | AIO-Studien-gGmbH | Not applicable | Recruiting | HCC - Hepatocellular Carcinoma | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924943) |
| November 4, 2026 | NCT07916376 | Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response | UNC Lineberger Comprehensive Cancer Center | Not applicable | Not yet recruiting | Hepatocellular Carcinoma, Liver Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916376) |
| October 26, 2026 | NCT07895342 | Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma | Radboud University Medical Center | Not applicable | Not yet recruiting | Hepatocellular Carcinoma Non-Resectable | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895342) |
| October 16, 2026 | NCT07877220 | Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration | M.D. Anderson Cancer Center | Not applicable | Not yet recruiting | Liver Tumors | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877220) |
| October 9, 2026 | NCT07867522 | Prevention of Bile Leakage After Liver Resection in Children | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Not applicable | Recruiting | Postoperative Bile Leak, Focal Liver Lesions | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867522) |
| October 8, 2026 | NCT07866612 | Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma | West China Hospital | Not applicable | Not yet recruiting | Hepatocellular Carcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866612) |
| September 17, 2026 | NCT07824583 | A Study Evaluating a New Radiation Treatment Workflow (NGDS) | Varian, a Siemens Healthineers Company | Not applicable | Recruiting | Lung Cancer (Diagnosis), Liver Cancer, Adult, Pancreatic Cancer, Thoracic Cancers, Abdominal Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824583) |
| August 31, 2026 | NCT07795437 | GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma | Peking University First Hospital | Not applicable | Recruiting | Hepatocellular Carcinoma (HCC) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795437) |
| August 24, 2026 | NCT07781176 | Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer Patients | Shanghai Zhongshan Hospital | Not applicable | Not yet recruiting | Primary Liver Cancer | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781176) |
| August 17, 2026 | NCT07768085 | Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT | Shengjing Hospital | Not applicable | Not yet recruiting | Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (Icc), Hepatic Metastasis, Hepatic Hemangioma, Cyst... | 40,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768085) |
| August 12, 2026 | NCT07760012 | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors | Peking University Third Hospital | Not applicable | Recruiting | Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760012) |
| August 7, 2026 | NCT07751783 | Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations | Kaohsiung Medical University Chung-Ho Memorial Hospital | Not applicable | Recruiting | Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751783) |
| July 29, 2026 | NCT07732504 | AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation | Tongji Hospital | Not applicable | Not yet recruiting | Hepatocellular Carcinoma (HCC) | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732504) |
| July 8, 2026 | NCT07690683 | Patients With Hepatocellular Carcinoma (HCC) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Not applicable | Not yet recruiting | Hepatocellular Carcinoma, Hepatocellular Cancer, Liver Diseases, Liver Cancer | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690683) |
| July 2, 2026 | NCT07681817 | Risk Stratification and Proactive Nursing Intervention for Acute Kidney Injury Following Interventional Therapy in Patients With Liver... | Tianjin Medical University Cancer Institute and Hospital | Not applicable | Not yet recruiting | Liver Cancer, Adult | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681817) |
| July 1, 2026 | NCT07677774 | GPC3-Targeted PET/CT in Hepatocellular Carcinoma | The First Affiliated Hospital of Xiamen University | Not applicable | Recruiting | Hepatocellular Carcinoma (HCC), Glypican-3, GPC3-targeted PET/CT | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07677774) |
| June 30, 2026 | NCT07675187 | HCC Risk and Monitoring in Patients With Type 2 Diabetes | National Taiwan University Hospital | Not applicable | Not yet recruiting | Type 2 Diabetes (T2DM), Hepatocellular Carcinoma (HCC) | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675187) |
| June 12, 2026 | NCT07645742 | Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors | West Virginia University | Not applicable | Not yet recruiting | Cancer (Advanced Stage) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645742) |
| June 10, 2026 | NCT07639801 | 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | Peking University Cancer Hospital & Institute | Not applicable | Not yet recruiting | Prostate Cancer, Hepatocellular Carcinoma, Ovarian Cancer, Solid Tumors, Endometrial Cancer, FAPI, PSMA | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639801) |
| June 5, 2026 | NCT07628751 | A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC | University Health Network, Toronto | Not applicable | Recruiting | Early Hepatocellular Carcinoma | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628751) |
| June 3, 2026 | NCT07623265 | Improving the Use of Immunotherapy to Treat Liver Cancer | Universitaire Ziekenhuizen KU Leuven | Not applicable | Recruiting | Hepatocellular Carcinoma (HCC) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623265) |
| June 1, 2026 | NCT07618546 | A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative... | Henan Cancer Hospital | Not applicable | Not yet recruiting | HCC - Hepatocellular Carcinoma | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07618546) |
| May 27, 2026 | NCT07608458 | Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy | City of Hope Medical Center | Not applicable | Not yet recruiting | Hepatocellular Carcinoma, Pancreas Cancer, Biliary Tract Neoplasms | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07608458) |
| May 5, 2026 | NCT07568457 | Social Determinants of Health HCC Trial | University of Southern California | Not applicable | Not yet recruiting | HCC - Hepatocellular Carcinoma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07568457) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Sun Yat-sen University | 9 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Third Affiliated Hospital, Sun Yat-Sen University | 4 |
| University of Aarhus | 4 |
| University Hospital, Angers | 3 |
| Nantes University Hospital | 3 |
| RenJi Hospital | 3 |
| Tongji Hospital | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Shanghai Zhongshan Hospital | 3 |
| Medical University of Warsaw | 2 |
| Chinese University of Hong Kong | 2 |
| National Taiwan University Hospital | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| National Cancer Centre, Singapore | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| West China Hospital | 2 |
| [Angiodynamics, Inc.](https://specstream.ai/data/clinical-trials/company/angiodynamics-inc) | 2 |
| Yonsei University | 2 |
| University of California, San Francisco | 2 |
| Henan Cancer Hospital | 2 |
| Zhongda Hospital | 2 |
| Fudan University | 2 |
| M.D. Anderson Cancer Center | 2 |
| Seoul National University Hospital | 2 |

## By country

| Country | Trials |
| --- | --- |
| China | 44 |
| United States | 23 |
| France | 16 |
| South Korea | 6 |
| Italy | 5 |
| Denmark | 4 |
| Hong Kong | 3 |
| Taiwan | 3 |
| Netherlands | 3 |
| United Kingdom | 3 |
| Belgium | 3 |
| Canada | 3 |
| Australia | 3 |
| Germany | 3 |
| Poland | 2 |
| Egypt | 2 |
| Singapore | 2 |
| Switzerland | 2 |
| India | 2 |
| Russia | 1 |
| Portugal | 1 |
| New Zealand | 1 |
| Japan | 1 |
| Austria | 1 |
| Norway | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Window suppliers in the United States](https://specstream.ai/data/businesses/window-suppliers/united-states)
- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
- [Promotional products companies in the United States](https://specstream.ai/data/businesses/promotional-products-companies/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [International fusion restaurants in the United States](https://specstream.ai/data/businesses/international-fusion-restaurants/united-states)
- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
